Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Chronic Kidney Disease

In brief

The purpose of this study is to examine the effect of mitochondria derived oxidative stress on vascular function in patients with moderate to severe Chronic Kidney Disease.

Key facts

Study ID

NCT02364648

Run by

University of Delaware

People needed

24

Starts

2017-07-01

Expected to finish

2019-09-30

Last updated by the study team

2019-04-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage 3 - 5 Chronic Kidney Disease

You may not qualify if…

• History of cardiovascular disease;
• Current pregnancy;
• Uncontrolled hypertension;
• Uncontrolled hyperlipidemia;
• Current hormone replacement therapy;
• Current use of tobacco products;
• Elevated liver enzymes;
• Current autoimmune disease;
• Daily use of of antioxidants >300mg

Where it is running

• Department of Kinesiology and Applied Physiology, University of Delaware — Newark, Delaware, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.